Clinical Trial Update: An Exploratory, Open Label, Single Center Study of [F-18]HX4 [EARLY_Phase 1]

View source ↗

Summary

An exploratory, open-label Phase 1 study of the radiotracer [F-18]HX4 in head and neck cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• [F-18]HX4

Snippet

Sponsor: Siemens Molecular Imaging | Conditions: Head and Neck Cancer | EARLY_Phase 1 | Status: COMPLETED